Frontiers in Bioengineering and Biotechnology

Additive manufacturing - an antidote to bottlenecks in tissue engineering and regenerative medicine

Figure 1 from Frontiers in Bioengineering and Biotechnology
Open the figure at full size
Figure 1. Li et al., CC BY

Abstract

Tissue engineering and regenerative medicine (TERM) has advanced by leveraging innovations in biomaterials, cell biology, and drug delivery, but its potential remains to be fully realized due to limitations in manufacturing complex cellular constructs.

The paper

University of Freiburg

Frontiers in Bioengineering and Biotechnology, 8 Sep 2026, CC BY

doi.org/10.3389/fbioe.2026.1929172PubMed 42807625